TBRIF (Therma Bright) FCF Margin % : -300.00% (As of Oct. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Therma Bright FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Therma Bright's Free Cash Flow for the three months ended in Oct. 2024 was $-0.01 Mil. Therma Bright's Revenue for the three months ended in Oct. 2024 was $0.00 Mil. Therefore, Therma Bright's FCF Margin % for the quarter that ended in Oct. 2024 was -300.00%.

As of today, Therma Bright's current FCF Yield % is -8.89%.

The historical rank and industry rank for Therma Bright's FCF Margin % or its related term are showing as below:

TBRIF' s FCF Margin % Range Over the Past 10 Years
Min: -78900 Med: -2745.48 Max: -574.19
Current: -3273.68

During the past 13 years, the highest FCF Margin % of Therma Bright was -574.19%. The lowest was -78900.00%. And the median was -2745.48%.

TBRIF's FCF Margin % is ranked worse than
97.21% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -3.57 vs TBRIF: -3273.68

Therma Bright FCF Margin % Historical Data

The historical data trend for Therma Bright's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Therma Bright FCF Margin % Chart

Therma Bright Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

FCF Margin %

Get a 7-Day Free Trial

-2,600.00

-83,933.33

-2,745.79

-10,272.22

-3,873.68

Therma Bright Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
FCF Margin %	Get a 7-Day Free Trial															-2,500.00	100.00	1,950.00	-13,880.00	-300.00

Competitive Comparison of Therma Bright's FCF Margin %

For the Medical Devices subindustry, Therma Bright's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Therma Bright's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Therma Bright's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Therma Bright's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Therma Bright FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Therma Bright's FCF Margin for the fiscal year that ended in Jul. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jul. 2024 )	/	Revenue (A: Jul. 2024 )
	=	-0.736	/	0.019
	=	-3,873.68 %

Therma Bright's FCF Margin for the quarter that ended in Oct. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Oct. 2024 )	/	Revenue (Q: Oct. 2024 )
	=	-0.012	/	0.004
	=	-300.00 %

Therma Bright FCF Margin % Related Terms

Thank you for viewing the detailed overview of Therma Bright's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Therma Bright Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Therma Bright Inc (OTCPK:TBRIF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

JNX:Germany THRM:Canada

Address

345 Danforth Avenue, Toronto, ON, CAN, M4K 1N7

Website

https://www.thermabright.com

Therma Bright Inc is a developer and partner in a range of proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on 3 key strategic areas: respiratory disease, vascular health, and consumer medical devices.